## Abstract Carbonate substitution within the hydroxyapatite (HA) lattice improves osteoconduction, although the mechanism by which this occurs is unclear. Discs of dense, sintered, phase‐pure HA and AB‐type carbonate substituted hydroxyapatite (CHA) were cultured for 21 days with human CD14+ cells
Human osteoblast response to silicon-substituted hydroxyapatite
✍ Scribed by C.M. Botelho; R.A. Brooks; S.M. Best; M.A. Lopes; J.D. Santos; N. Rushton; W. Bonfield
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 495 KB
- Volume
- 79A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Human osteoblasts were cultured on hydroxyapatite (HA), 0.8 wt % silicon substituted hydroxyapatite (Si‐HA) and 1.5 wt % Si‐HA discs. The influence of these substrates on cell behaviour in vitro was assessed by measuring total protein in the cell lysate and the production of several phenotypic markers: collagen type I (COL I), alkaline phosphatase (ALP), osteocalcin (OC), and the formation of bone mineral. After 7 days, β‐glycerophosphate and physiological levels of hydrocortisone were added to the culture medium to stimulate cell differentiation and mineral production. There was a significantly higher production of ALP on 1.5 wt % Si‐HA at day 7 following which, the addition of hydrocortisone promoted the differentiation of cells on the other two substrates. Hydrocortisone addition also decreased the production of OC. During the period, when hydrocortisone was present, no significant difference in behavior was seen between cells on Si‐HA and HA; however, following removal of hydrocortisone, cells responded to 0.8 wt % Si‐HA with a significant increase in protein production. Using fluorescence microscopy, nodular structures labeled with tetracycline were observed on the surface of all substrates after 21 days. These structures were deposited on areas of high cell density but were not related to the presence or level of silicon in the substrate. These results indicate that human osteoblasts are affected by the presence of silicon in the HA substrate and that the timing of these effects may be dependent upon the level of silicon substitution. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006
📜 SIMILAR VOLUMES
## Abstract Hydroxyapatite/soluble calcium phosphate composites (HAp/SCaP) are novel HAp‐based materials with enhanced solubility that have been developed by annealing HAp in a vacuum. This study compared the effects of HAp and HAp/SCaP on osteoblast proliferation, differentiation, and mineralizati
## Abstract Nano‐sized hydroxyapatite (HA) powders were produced by a hydrothermal method and a precipitation method. Spark plasma sintering (SPS) was used to fabricate nanostructured HA (NHA) using nano‐sized HA powders as a precursor. Conventional sintering was employed to produce microstructured
## Abstract Hydroxyapatite‐reinforced high‐density polyethylene (HA‐HDPE) composite, as a bone replacement material, has successfully been used clinically as middle ear prostheses and orbital floor implants. The aim of this study was to examine its __in vitro__ biocompatibility in order to develop
## Abstract Hydroxyapatite has been successfully deposited onto Fecralloy substrate (a metal alloy with 22% Cr, 4.8% Al) by electrophoretic deposition in an attempt to promote the adhesion between coating and substrate, consequently to extend the lifetime of implants. Fecralloy has the ability to g
## Abstract Polycaprolactone (PCL), a semicrystalline linear resorbable aliphatic polyester, is a good candidate as a scaffold for bone tissue engineering, due to its biocompatibility and biodegradability. However, the poor mechanical properties of PCL impair its use as scaffold for hard tissue reg